Since there was no mention of TINY's participation in the round, I would assume dilution cancels the cash infusion as relates to TINY's NAV. Nantero's performance in its NRAM business will determine if this is good or bad for Harris and Harris. It does show faith in Nantero from a group of investors. Sorry to be so simplistic. I was really only reporting news that had been ignored. I am most excited about the position in SZYM.